Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.62
+0.23 (2.02%)
Jun 18, 2025, 4:00 PM - Market closed
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $885.86 million as of June 18, 2025. Its market cap has decreased by -6.95% in one year.
Market Cap
885.86M
Enterprise Value
362.80M
1-Year Change
-6.95%
Ranking
Category
Stock Price
$11.62
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $885.86M, an increase of 25.82%. That is a compound annual growth rate of 4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 885.86M | -33.62% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.99B |
| Johnson & Johnson | 373.47B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.09B |
| Abbott Laboratories | 233.16B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |